Accure Acne Inc.™ announces the appointment of Jeffrey O’Donnell, Sr. to the Board

Accure Acne, Inc. announced today that Jeffrey O’Donnell, Sr. has joined Accure Acne’s Board of Directors. Along with Chairman and Founder Christopher Carlton and Founder Ed Barbera, Mr. O’Donnell provides strategic guidance for Accure’s investment, organization, commercialization and clinical development of the Accure laser, as the company continues to focus on delivering a durable treatment for acne to patients around the world.

“The addition of Jeff to our board strengthens Accure considerably,” said Mr. Carlton. “Jeff’s experience in this industry, and relationships with key opinion leaders and venture partners, comes at a critical time as Accure conducts its current Series A financing round; the proceeds of which will fund commercialization in the EU with our first-to-market CE-Mark clearance and continuing to execute our FDA pivotal trial here in the US.”

Find out more in the press release.

Categories: Ecosystem News